140 related articles for article (PubMed ID: 3668385)
1. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
Batta AK; Salen G; Shefer S; Tint GS; Batta M
J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
[TBL] [Abstract][Full Text] [Related]
2. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
[TBL] [Abstract][Full Text] [Related]
3. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis.
Kuramoto T; Suemura Y; Kihira K; Hiraoka T; Hoshita T
Steroids; 1995 Oct; 60(10):709-12. PubMed ID: 8539780
[TBL] [Abstract][Full Text] [Related]
4. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
Batta AK; Shefer S; Batta M; Salen G
J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide in serum of patients with cerebrotendinous xanthomatosis.
Une M; Kataoka J; Nakata Y; Hoshita T
Steroids; 1992 Jan; 57(1):32-6. PubMed ID: 1585391
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis.
Hoshita T; Yasuhara M; Une M; Kibe A; Itoga E; Kito S; Kuramoto T
J Lipid Res; 1980 Nov; 21(8):1015-21. PubMed ID: 7462799
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis.
Salen G; Batta AK; Tint GS; Shefer S
Metabolism; 1994 Aug; 43(8):1018-22. PubMed ID: 8052141
[TBL] [Abstract][Full Text] [Related]
8. Determination of the glucurono-conjugated position in bile alcohol glucuronides excreted in urine of a patient with cerebrotendinous xanthomatosis by a nuclear magnetic resonance study.
Kuramoto T; Fukuda K; Ohshima A; Kihira K; Hoshita T
J Biochem; 1994 Apr; 115(4):655-8. PubMed ID: 8089079
[TBL] [Abstract][Full Text] [Related]
9. Biochemical studies of inherited diseases related to abnormal cholesterol metabolism. I. High-performance liquid chromatographic analysis of bile alcohol glucuronides in cerebrotendinous xanthomatosis.
Ohshima A; Kuramoto T; Hoshita T
Biol Pharm Bull; 1994 May; 17(5):721-3. PubMed ID: 7920441
[TBL] [Abstract][Full Text] [Related]
10. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis.
Yasuhara M; Kuramoto T; Hoshita T; Itoga E; Kito S
Steroids; 1978 Mar; 31(3):333-45. PubMed ID: 663972
[TBL] [Abstract][Full Text] [Related]
11. Identification of (23S)-5 alpha-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in urine of patients with cerebrotendinous xanthomatosis.
Kihira K; Fukuda K; Kuramoto T; Kuriyama M; Fujiyama J; Osame M; Hoshita T
Steroids; 1991 Sep; 56(9):464-8. PubMed ID: 1805458
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
Wolthers BG; Volmer M; van der Molen J; Koopman BJ; de Jager AE; Waterreus RJ
Clin Chim Acta; 1983 Jun; 131(1-2):53-65. PubMed ID: 6883710
[TBL] [Abstract][Full Text] [Related]
13. Absolute configuration at carbon 23 of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol excreted by patients with cerebrotendinous xanthomatosis.
Kihira K; Kubota A; Hoshita T
J Lipid Res; 1984 Aug; 25(8):871-5. PubMed ID: 6491531
[TBL] [Abstract][Full Text] [Related]
14. Bile alcohol glucuronides: regioselective O-glucuronidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol and 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol.
Dayal B; Salen G; Padia J; Shefer S; Tint GS; Sasso G; Williams TH
Carbohydr Res; 1993 Feb; 240():133-42. PubMed ID: 8458007
[TBL] [Abstract][Full Text] [Related]
15. Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.
Koopman BJ; Wolthers BG; van der Molen JC; Waterreus RJ
Clin Chim Acta; 1985 Oct; 152(1-2):115-22. PubMed ID: 4053393
[TBL] [Abstract][Full Text] [Related]
16. Identification of bile alcohols in human bile.
Kuroki S; Shimazu K; Kuwabara M; Une M; Kihira K; Kuramoto T; Hoshita T
J Lipid Res; 1985 Feb; 26(2):230-40. PubMed ID: 3989382
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis.
Dayal B; Tint GS; Toome V; Batta AK; Shefer S; Salen G
J Lipid Res; 1985 Mar; 26(3):298-305. PubMed ID: 2985722
[TBL] [Abstract][Full Text] [Related]
18. Identification of bile alcohols in serum from healthy humans.
Hiraoka T; Kihira K; Kosaka D; Kohda T; Hoshita T; Kajiyama G
Steroids; 1988; 51(5-6):543-50. PubMed ID: 3242175
[TBL] [Abstract][Full Text] [Related]
19. Detection of carriers of cerebrotendinous xanthomatosis.
Koopman BJ; Waterreus RJ; Van den Brekel HW; Wolthers BG
Clin Chim Acta; 1986 Jul; 158(2):179-85. PubMed ID: 3742821
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
Salen G; Shefer S; Tint GS; Nicolau G; Dayal B; Batta AK
J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
